Pharmaceuticals in Japan

Publication ID:

MLI05200163

Publication Date:

May 28, 2020

Pages:

Publisher:

麻豆原创Line

Countries:

Japan [1]

USD 350.00

Pharmaceutical Manufacturing [2]

Pharma & Healthcare [3]

Description:

Pharmaceuticals in Japan

Summary

Pharmaceuticals in Japan industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The Japanese pharmaceuticals market had total revenues of $59,300.0m in 2019, representing a compound annual rate of change (CARC) of -3.1% between 2015 and 2019.
- The fundamentals of the market - its aging population and focus on innovation - remain strong. However, debate is ongoing about the best, sustainable, way to incentivize pharmaceutical innovation with respect to the price of drugs.
- To promote its domestic industry and attract new companies to the market, it has acted to accelerate the approval of new innovative drugs and eased pharmaceutical regulation.

Scope

- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Japan
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Japan
- Leading company profiles reveal details of key pharmaceuticals market players鈥� global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Japan pharmaceuticals market with five year forecasts

Reasons to Buy

- What was the size of the Japan pharmaceuticals market by value in 2019?
- What will be the size of the Japan pharmaceuticals market in 2024?
- What factors are affecting the strength of competition in the Japan pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitiors in Japan's pharmaceuticals market?

Table Of Contents:

Table of Contents
1 Executive Summary
1.1. 麻豆原创 value
1.2. 麻豆原创 value forecast
1.3. Geography segmentation
1.4. 麻豆原创 share
1.5. 麻豆原创 rivalry
1.6. Competitive Landscape
2 麻豆原创 Overview
2.1. 麻豆原创 definition
2.2. 麻豆原创 analysis
3 麻豆原创 Data
3.1. 麻豆原创 value
4 麻豆原创 Segmentation
4.1. Geography segmentation
5 麻豆原创 Outlook
5.1. 麻豆原创 value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. 麻豆原创 share
7.2. Who are the leading players?
7.3. What are the strengths/weaknesses of leading players?
7.4. What strategies do leading players follow?
7.5. What has been the rationale behind recent M&A activity?
8 Company Profiles
8.1. Daiichi Sankyo Co Ltd
8.2. Takeda Pharmaceutical Company Limited
8.3. Astellas Pharma Inc.
8.4. Mitsubishi Tanabe Pharma Corporation
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related 麻豆原创Line research
10.4. About 麻豆原创Line

List of Tables
List of Tables
Table 1: Japan pharmaceuticals market value: $ billion, 2015-19
Table 2: Japan pharmaceuticals market geography segmentation: $ billion, 2019
Table 3: Japan pharmaceuticals market value forecast: $ billion, 2019-24
Table 4: Japan pharmaceuticals market share: % share, by value, 2019
Table 5: Daiichi Sankyo Co Ltd: key facts
Table 6: Daiichi Sankyo Co Ltd: Annual Financial Ratios
Table 7: Daiichi Sankyo Co Ltd: Key Employees
Table 8: Daiichi Sankyo Co Ltd: Key Employees Continued
Table 9: Daiichi Sankyo Co Ltd: Key Employees Continued
Table 10: Daiichi Sankyo Co Ltd: Key Employees Continued
Table 11: Takeda Pharmaceutical Company Limited: key facts
Table 12: Takeda Pharmaceutical Company Limited: Annual Financial Ratios
Table 13: Takeda Pharmaceutical Company Limited: Annual Financial Ratios (Continued)
Table 14: Takeda Pharmaceutical Company Limited: Key Employees
Table 15: Takeda Pharmaceutical Company Limited: Key Employees Continued
Table 16: Astellas Pharma Inc.: key facts
Table 17: Astellas Pharma Inc.: Annual Financial Ratios
Table 18: Astellas Pharma Inc.: Key Employees
Table 19: Astellas Pharma Inc.: Key Employees Continued
Table 20: Mitsubishi Tanabe Pharma Corporation: key facts
Table 21: Mitsubishi Tanabe Pharma Corporation: Annual Financial Ratios
Table 22: Mitsubishi Tanabe Pharma Corporation: Key Employees
Table 23: Japan size of population (million), 2015-19
Table 24: Japan gdp (constant 2005 prices, $ billion), 2015-19
Table 25: Japan gdp (current prices, $ billion), 2015-19
Table 26: Japan inflation, 2015-19
Table 27: Japan consumer price index (absolute), 2015-19
Table 28: Japan exchange rate, 2015-19

List of Figures
List of Figures
Figure 1: Japan pharmaceuticals market value: $ billion, 2015-19
Figure 2: Japan pharmaceuticals market geography segmentation: % share, by value, 2019
Figure 3: Japan pharmaceuticals market value forecast: $ billion, 2019-24
Figure 4: Forces driving competition in the pharmaceuticals market in Japan, 2019
Figure 5: Drivers of buyer power in the pharmaceuticals market in Japan, 2019
Figure 6: Drivers of supplier power in the pharmaceuticals market in Japan, 2019
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Japan, 2019
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Japan, 2019
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Japan, 2019
Figure 10: Japan pharmaceuticals market share: % share, by value, 2019

Companies Mentioned:

Daiichi Sankyo Co Ltd
Takeda Pharmaceutical Company Limited
Astellas Pharma Inc.
Mitsubishi Tanabe Pharma Corporation

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.